Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.65%
#2 Victoria VR Victoria VR +11.02%
#3 Palladium Network Palladium Network +8.55%
#4 Cryptopia Cryptopia +4.36%
#5 COTI COTI +3.80%
#6 GRVT Token GRVT Token +2.92%
#7 Lisk Lisk +2.64%
#8 NEAR Intents Bridged ZEC NEAR Intents Bridged ZEC +2.61%
#9 Kinetiq Kinetiq +2.57%
#10 Lighter Lighter +2.56%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
PhaseRx, Inc. PhaseRx, Inc.

PhaseRx, Inc.

PZRXQ
Classificação em ações #42474
PhaseRx, Inc. is a biopharmaceutical company dedicated to developing treatments... PhaseRx, Inc. is a biopharmaceutical company dedicated to developing treatments for inherited enzyme deficiencies affecting the liver. Its therapeutic strategy involves intracellular enzyme replacement, powered by its unique Hybrid mRNA technology platform, which facilitates the production of absent enzymes directly within the body's cells. The company's pipeline includes several programs targeting urea cycle disorders, such as PRX-OTC for ornithine transcarbamylase deficiency, PRX-ASL for argininosuccinate lyase deficiency, and PRX-ASS1 for argininosuccinate synthetase deficiency. Established in 2006, PhaseRx is headquartered in Seattle, Washington.
Preço da ação
$0.0001
Última sincronização: 2026-08-11
Valor de mercado
$1.17K
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar PhaseRx, Inc. (PZRXQ)

Categoria

Healthcare
Histórico de preços das ações de PhaseRx, Inc. (PZRXQ)
Preço de fecho mais alto: $0.00 em 2026-08-01

Preço de fecho mais baixo: $5.21 em 2016-05-01
Histórico de preços das ações da PhaseRx, Inc. de 2016 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) 0.00%
2025 -52.25%
2024 0.00%
2023 100.00%
2022 -4.35%
2021 -96.33%
2020 62.38%
2019 -37.88%
2018 -99.53%
2017 -62.39%
2016 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.87 33.33%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $873.57 35.10%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.38 7.69%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $263.09 18.09%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -7.57%
KR